Company / Financials
TREACE MEDICAL CONCEPTS, INC. Financials
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$187.1M
FY2025 · +31.9% YoY
Net Income
-$49.5M
FY2025 · -15.7% YoY
Profit Margin
-26.5%
FY2025 · net income / revenue
ROE
-43.9%
FY2025 · return on equity
Total Assets
$190.6M
FY2025
Total Debt
$55.6M
0.49x debt/equity
Equity
$112.9M
FY2025
ROA
-26.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$187.1M+31.9% YoYNet Income HistoryProfit after all expenses and taxes-$49.5M-15.7% YoYGross Profit HistoryRevenue minus cost of goods sold$151.9M+30.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$35.2M+37.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$51.4M-47.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$47.0M+42.5% YoYR&D Expense HistoryResearch and development spending$15.4M+13.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$5.2M+17.5% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$0.81-5.2% YoY